<unk> , sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia. Promacta<unk>  is known as Revolade® outside the U.S. and is marketed worldwide by Novartis. It is a thrombopoietin receptor agonist.<unk>  was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals and is transferred to Novartis Pharmaceuticals.
Eltrombopag
Avatrombopag
Lusutrombopag
Ximelagatran
Hirudin
Tirbanibulin
Anistreplase
Desmoteplase